Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression ; volume:50 ; number:1 ; year:2020 ; pages:130-137 ; extent:8
European journal of immunology ; 50, Heft 1 (2020), 130-137 (gesamt 8)
- Urheber
-
McCarthy, Michael T.
Lin, Da
Soga, Tomoyoshi
Adam, Julie
O'Callaghan, Christopher A.
- DOI
-
10.1002/eji.201847948
- URN
-
urn:nbn:de:101:1-2022062707283257722200
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McCarthy, Michael T.
- Lin, Da
- Soga, Tomoyoshi
- Adam, Julie
- O'Callaghan, Christopher A.
Ähnliche Objekte (12)
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Cutting an NKG2D ligand short : cellular processing of the peculiar human NKG2D ligand ULBP4
Chronic NKG2D engagement in vivo differentially impacts NK cell responsiveness by activating NK receptors
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma
The NKG2D ligand ULBP4 is not expressed by human monocytes
The NKG2D ligand ULBP4 is not expressed by human monocytes
Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on NK Cells Protects From Hepatic Ischemia-Reperfusion Injury
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Der NK-Zellrezeptor NKG2D als Zielstruktur für eine Antikörper-basierte therapeutische Immunmodulation
Fc-optimierte NKG2D-Fusionsproteine zur Induktion von NK-Zell Reaktivität gegen Leukämien
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Cutting an NKG2D ligand short : cellular processing of the peculiar human NKG2D ligand ULBP4
Chronic NKG2D engagement in vivo differentially impacts NK cell responsiveness by activating NK receptors
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma
The NKG2D ligand ULBP4 is not expressed by human monocytes
The NKG2D ligand ULBP4 is not expressed by human monocytes
Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on NK Cells Protects From Hepatic Ischemia-Reperfusion Injury
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Der NK-Zellrezeptor NKG2D als Zielstruktur für eine Antikörper-basierte therapeutische Immunmodulation
Fc-optimierte NKG2D-Fusionsproteine zur Induktion von NK-Zell Reaktivität gegen Leukämien
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Cutting an NKG2D ligand short : cellular processing of the peculiar human NKG2D ligand ULBP4
Chronic NKG2D engagement in vivo differentially impacts NK cell responsiveness by activating NK receptors
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma
The NKG2D ligand ULBP4 is not expressed by human monocytes
The NKG2D ligand ULBP4 is not expressed by human monocytes
Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on NK Cells Protects From Hepatic Ischemia-Reperfusion Injury
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Der NK-Zellrezeptor NKG2D als Zielstruktur für eine Antikörper-basierte therapeutische Immunmodulation